STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

CorVel Announces Revenues and Earnings

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

CorVel (NASDAQ: CRVL) reported strong financial results for Q1 FY2025 ended June 30, 2024. Revenue increased 11% to $212 million, while gross profit rose 15% to $48.2 million with a 22.7% gross margin. Diluted earnings per share grew 10% to $1.25. The company ended the quarter with $132 million in cash and no borrowings, while repurchasing $9.5 million of common stock.

CorVel introduced an enhanced communications platform integrated into its CareMC claims system, improving efficiency and security. The company is also leveraging artificial intelligence for clinical bill review and anomaly detection, aiming to enhance outcomes, worker experience, and team satisfaction.

Loading...
Loading translation...

Positive

  • Revenue increased 11% year-over-year to $212 million
  • Gross profit grew 15% to $48.2 million, with improved gross margin of 22.7%
  • Diluted earnings per share increased 10% to $1.25
  • Strong cash position of $132 million with no borrowings
  • Introduced enhanced communications platform integrated with CareMC claims system
  • Implemented AI for clinical bill review and anomaly detection

Negative

  • None.

News Market Reaction 1 Alert

+3.95% News Effect

On the day this news was published, CRVL gained 3.95%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FORT WORTH, Texas, July 30, 2024 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended June 30, 2024. Revenues for the quarter were $212 million, an increase from $190 million in the June quarter of 2023. Earnings per share for the quarter were $1.25, compared to $1.14 in the same quarter of the prior year.  

First Quarter Fiscal Year 2025 Highlights 

  • Revenue increased 11% to $212 million, compared to first quarter of fiscal year 2024.
  • Gross profit increased 15% to $48.2 million, at 22.7% gross margin, compared to first quarter of fiscal year 2024 gross profit of $41.9 million.
  • Diluted earnings per share increased 10% to $1.25, compared to first quarter of fiscal year 2024 diluted earnings per share of $1.14.
  • Exited the quarter with $132 million of cash, cash equivalents, and no borrowings.
  • The Company repurchased $9.5 million of common stock during the quarter.

During the quarter, the Company introduced an enhanced communications platform integrated in CorVel’s proprietary claims system, CareMC. This platform benefits claim staff and injured workers and yields a level of efficiency that is unique in the industry. Additionally, the platform utilizes the advanced security features embedded in the system, reducing patient security risk.

Artificial intelligence is also being used in the review of clinical bills to identify anomalies and document activities. This utilization of AI allows the users to focus on reviewing procedures and achieving optimal cost containment. The Company believes the use of AI in partnership with the CorVel team will provide improved outcomes for partners, enhanced experience for workers with injuries, and increased job satisfaction for team members.  

About CorVel

CorVel Corporation applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. We partner with employers, third-party administrators, insurance companies and government agencies in managing workers’ compensation and health, auto and liability services. Our diverse suite of solutions combines our integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to our improved productivity resulting from automation and augmentation across enterprise business systems.  These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement, including the risk that the impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment.  The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024 and the Company’s Quarterly Report on Form 10-Q for the quarters ended June 30, 2023, September 30, 2023 and December 31, 2023. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.

CorVel Corporation
Quarterly Results – Income Statement
Quarters Ended June 30, 2024 (unaudited) and June 30, 2023 (unaudited)

 
Quarter Ended June 30, 2024  June 30, 2023 
Revenues $211,722,000  $190,253,000 
Cost of revenues  163,567,000   148,375,000 
Gross profit  48,155,000   41,878,000 
General and administrative  20,120,000   16,450,000 
Income from operations  28,035,000   25,428,000 
Income tax provision  6,458,000   5,623,000 
Net income $21,577,000  $19,805,000 
Earnings Per Share:      
Basic $1.26  $1.16 
Diluted $1.25  $1.14 
Weighted Shares      
Basic  17,122,000   17,144,000 
Diluted  17,313,000   17,385,000 


CorVel Corporation
Quarterly Results – Condensed Balance Sheet
June 30, 2024 (unaudited) and March 31, 2024

 
  June 30, 2024  March 31, 2024 
Cash $131,908,000  $105,563,000 
Customer deposits  94,022,000   88,142,000 
Accounts receivable, net  97,749,000   97,108,000 
Prepaid taxes and expenses  9,579,000   11,418,000 
Property, net  86,865,000   85,892,000 
Goodwill and other assets  42,808,000   42,498,000 
Right-of-use asset, net  23,241,000   24,058,000 
Total $486,172,000  $454,679,000 
Accounts and taxes payable $18,681,000  $16,631,000 
Accrued liabilities  181,904,000   167,868,000 
Long-term lease liabilities  21,714,000   22,533,000 
Paid-in capital  237,807,000   233,632,000 
Treasury stock  (803,431,000)  (793,905,000)
Retained earnings  829,497,000   807,920,000 
Total $486,172,000  $454,679,000 


Contact: Melissa Storan
Phone: 949-851-1473
www.corvel.com


FAQ

What was CorVel's (CRVL) revenue for Q1 FY2025?

CorVel reported revenue of $212 million for Q1 FY2025, an 11% increase from $190 million in the same quarter of the previous year.

How much did CorVel's (CRVL) earnings per share grow in Q1 FY2025?

CorVel's diluted earnings per share increased 10% to $1.25 in Q1 FY2025, compared to $1.14 in the same quarter of the previous year.

What was CorVel's (CRVL) gross profit and margin for Q1 FY2025?

CorVel's gross profit for Q1 FY2025 increased 15% to $48.2 million, with a gross margin of 22.7%.

How much cash did CorVel (CRVL) have at the end of Q1 FY2025?

CorVel exited Q1 FY2025 with $132 million in cash and cash equivalents, with no borrowings.

What new technology did CorVel (CRVL) introduce in Q1 FY2025?

CorVel introduced an enhanced communications platform integrated into its CareMC claims system and implemented artificial intelligence for clinical bill review and anomaly detection.
Corvel Corp

NASDAQ:CRVL

CRVL Rankings

CRVL Latest News

CRVL Latest SEC Filings

CRVL Stock Data

3.62B
28.81M
43.75%
54.55%
1.17%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
IRVINE